Maxcyte (MXCT) Retained Earnings (2020 - 2025)
Historic Retained Earnings for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to -$251.9 million.
- Maxcyte's Retained Earnings fell 2212.35% to -$251.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$251.9 million, marking a year-over-year decrease of 2212.35%. This contributed to the annual value of -$216.9 million for FY2024, which is 2335.35% down from last year.
- Maxcyte's Retained Earnings amounted to -$251.9 million in Q3 2025, which was down 2212.35% from -$239.5 million recorded in Q2 2025.
- Maxcyte's Retained Earnings' 5-year high stood at -$106.7 million during Q2 2021, with a 5-year trough of -$251.9 million in Q3 2025.
- Its 5-year average for Retained Earnings is -$167.9 million, with a median of -$164.9 million in 2023.
- In the last 5 years, Maxcyte's Retained Earnings tumbled by 1862.52% in 2022 and then tumbled by 2814.76% in 2023.
- Quarter analysis of 5 years shows Maxcyte's Retained Earnings stood at -$114.3 million in 2021, then fell by 20.62% to -$137.9 million in 2022, then fell by 27.51% to -$175.8 million in 2023, then dropped by 23.35% to -$216.9 million in 2024, then dropped by 16.16% to -$251.9 million in 2025.
- Its last three reported values are -$251.9 million in Q3 2025, -$239.5 million for Q2 2025, and -$227.1 million during Q1 2025.